PharmaTher Holdings (XCNQ:PHRM) ROE % Adjusted to Book Value : -6.81% (As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings ROE % Adjusted to Book Value?

PharmaTher Holdings's ROE % for the quarter that ended in Feb. 2024 was -51.06%. PharmaTher Holdings's PB Ratio for the quarter that ended in Feb. 2024 was 7.50. PharmaTher Holdings's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 was -6.81%.

PharmaTher Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for PharmaTher Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings ROE % Adjusted to Book Value Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

ROE % Adjusted to Book Value

13.99

-41.13

-41.32

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-21.71	-57.01	-36.92	-24.57	-6.81

Competitive Comparison of PharmaTher Holdings's ROE % Adjusted to Book Value

For the Biotechnology subindustry, PharmaTher Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's ROE % Adjusted to Book Value falls into.

PharmaTher Holdings ROE % Adjusted to Book Value Calculation

PharmaTher Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in May. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-74.38%	/	1.80
	=	-41.32%

PharmaTher Holdings's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-51.06%	/	7.50
	=	-6.81%

PharmaTher Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines